ARPA-H Biomedical Research Agency Gets Funding Boost In US House Appropriations Bill
Progress on appropriations follows passage of legislation in the House formally authorizing the new agency dedicated to advancing cutting edge research.
You may also be interested in...
Packaging for such products reflects ‘unique circumstances’ that should exempt them from the rebates on discarded drugs otherwise required by the policy, stakeholders tell CMS at a ‘town hall’ forum.
Third Circuit is first of three federal appeals courts to issue a decision in multiple lawsuits over drug companies’ 340B contract pharmacy restrictions, which have led to conflicting lower court rulings on whether such restrictions are unlawful.
The early February date for publishing the list of products eligible for price negotiations could dictate approval strategies for drugs with potential for big sales in Medicare going forward.